Corvus Pharmaceuticals, Inc. - Common Stock (NQ:CRVS)

9.730 UNCHANGED

Delayed Quote Updated: 4:00 PM EST, Nov 5, 2026 Add to My Watchlist

Price and Volume

Volume	0
Open	9.730
Bid (Size)	9.500 (200)
Ask (Size)	11.00 (200)
Prev. Close	9.730
Today's Range	9.730 - 9.730
52wk Range	6.390 - 26.95
Shares Outstanding	84,090,424
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

What Corvus Pharmaceuticals (CRVS) Said on Its Q3 Earnings Call ↗

November 05, 2026

Corvus Pharmaceuticals (NASDAQ:CRVS) reported a wider third-quarter loss as spending on clinical trials increased, while executives outlined a series of 2027 milestones for its lead experimental drug,...

Via MarketBeat

Corvus Pharmaceuticals (CRVS) Q2 2026 Earnings Call Transcript ↗

August 14, 2026

Soquelitinib advances across multiple indications, with cash runway extended into 2028.

Via The Motley Fool

Performance

52-Week Range 63.9% below 52-week high

9.730

6.3952W Low 26.9552W High

1 Week 8.1% below 1-week high

9.581W Low 10.591W High

Corvus Pharmaceuticals, Inc. - Common Stock (CRVS) traded between $6.39 and $26.95 over the past 52 weeks and last traded at $9.73, 63.9% below its 52-week high. Over the past week it ranged between $9.58 and $10.59.

Past 12 Months

-3.0%

-7.9%

-29.8%

-33.3%

+32.9%

+29.2%

1W -$0.30

1M -$0.83

3M -$4.13

6M -$4.86

YTD +$2.41

1Y +$2.20

CRVS was +29.2% over the past year, -33.3% over six months, +32.9% year to date, -3.0% in the last week.

12 Months vs Market

CRVS

+29.2%

DIA

+8.7%

SPY

+8.2%

QQQ

+3.8%

IWM

+10.7%

Over the past 12 months CRVS returned +29.2% versus DIA (Dow) +8.7%, SPY (S&P 500) +8.2%, QQQ (Nasdaq 100) +3.8% and IWM (Russell 2000) +10.7%.

Volume & Liquidity

1.1M

1.0M

1.2M

YTD

1.9M

1.8M

CRVS's 3-month average daily volume is 1.0M.

More News

Corvus Pharmaceuticals Q2 Earnings Call Highlights ↗

August 06, 2026

Via MarketBeat

Corvus Pharmaceuticals (NASDAQ:CRVS) Misses Q2 Loss Estimates as Clinical-Stage Spending Continues ↗

August 06, 2026

Via Chartmill

Corvus Pharmaceuticals Reports Q1 2026 Results; Atopic Dermatitis Program Takes Center Stage (NASDAQ:CRVS) ↗

May 07, 2026

Via Chartmill

Corvus Pharmaceuticals (NASDAQ:CRVS) Reports Q4 Earnings Miss Amid Positive Pipeline Data ↗

March 12, 2026

Via Chartmill

Why Is CRVS Stock Rising Today? ↗

January 20, 2026

Via Stocktwits

Corvus Pharmaceuticals Director Buys 21,700 Shares. Does This Mean CRVS a Buy? ↗

June 23, 2026

Via The Motley Fool

Adams Street Partners Exits Its 223,000-Share Paymentus (PAY) Position for $5.9 Million ↗

May 24, 2026

Via The Motley Fool

Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase ↗

May 17, 2026

Via The Motley Fool

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Corvus (CRVS) Q4 2025 Earnings Call Transcript ↗

March 12, 2026

Via The Motley Fool

Momentum Is Just Starting for These 3 Rapid-Growth Stocks in 2026 ↗

February 02, 2026

Via MarketBeat

CRVS Stock Surges Pre-Market After Corvus Expands Equity Raise To $175 Million ↗

January 22, 2026

Via Stocktwits

Dow, Nasdaq, S&P 500 Futures Tick Higher After Wall Street’s Worst Day In 3 Months: Why NFLX, AAPL, CRVS, GME, UAL Are In Focus Today ↗

January 20, 2026

Via Stocktwits

Corvus Pharma Stock Dips Over 6% After-Hours Following Best Day Ever — What Went Wrong? ↗

January 20, 2026

Via Stocktwits

Stock Market Today, Jan. 20: Corvus Pharmaceuticals Surges After Positive Phase 1 Eczema Drug Data ↗

January 20, 2026

Via The Motley Fool

Here are the top movers in Tuesday's session. ↗

January 20, 2026

Via Chartmill

Tuesday's session: top gainers and losers ↗

January 20, 2026

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

January 20, 2026

Via Chartmill

Wondering what's happening in today's pre-market session? ↗

January 20, 2026

Via Chartmill

Corvus Pharmaceuticals Inc (NASDAQ:CRVS) Reports Narrower-Than-Expected Q2 2025 Loss, Shares Rise on Clinical Progress ↗

August 07, 2025

Via Chartmill

Corvus (CRVS) Q2 Loss Beats Estimates ↗

August 07, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 09, 2025

Via Benzinga

Frequently Asked Questions

Is Corvus Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Corvus Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Corvus Pharmaceuticals, Inc. - Common Stock trade on?

Corvus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Corvus Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Corvus Pharmaceuticals, Inc. - Common Stock is CRVS on the Nasdaq Stock Market

What is the current price of Corvus Pharmaceuticals, Inc. - Common Stock?

The current price of Corvus Pharmaceuticals, Inc. - Common Stock is 9.730

When was Corvus Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Corvus Pharmaceuticals, Inc. - Common Stock was at 11/05/26 04:00 PM ET

What is the market capitalization of Corvus Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Corvus Pharmaceuticals, Inc. - Common Stock is 818.20M

How many shares of Corvus Pharmaceuticals, Inc. - Common Stock are outstanding?

Corvus Pharmaceuticals, Inc. - Common Stock has 818M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.